Type 1 diabetes through the life span: a position statement of the American Diabetes Association

doi:10.2337/dc14-1140

. 2014 Jul;37(7):2034-54.

doi: 10.2337/dc14-1140.

Type 1 diabetes through the life span: a position statement of the American Diabetes Association

Jane L Chiang¹, M Sue Kirkman², Lori M B Laffel³, Anne L Peters⁴; Type 1 Diabetes Sourcebook Authors

Collaborators, Affiliations

Collaborators

Type 1 Diabetes Sourcebook Authors:
Nora Algothani, Pamela Allweiss, Barbara J Anderson, Florence M Brown, H Peter Chase, William L Clarke, Sheri R Colberg, Kathleen Dungan, Steven Edelman, Martha M Funnell, Stephen E Gitelman, Ann E Goebel-Fabbri, Jeffrey S Gonzalez, Carla J Greenbaum, Michael J Haller, Kara Hawkins, Laurie A Higgins, Irl B Hirsch, William C Hsu, Heba Ismail, Crystal Crismond Jackson, Tamarra James-Todd, Georgeanna J Klingensmith, David C Klonoff, Mary Korytkowski, David Maahs, Hussain Mahmud, Medha N Munshi, Trevor Orchard, Bruce A Perkins, Jeremy Hodson Pettus, Andrew M Posselt, Michael C Riddell, Elizabeth R Seaquist, Janet Silverstein, Linda M Siminerio, Peter Stock, William V Tamborlane, Guillermo E Umpierrez, Raynard Washington, Joseph I Wolfsdorf, Howard Wolpert, Jennifer Ann Wyckoff, Mary Ziotas Zacharatos

Affiliations

¹ American Diabetes Association, Alexandria, VA jchiang@diabetes.org.
² Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.
³ Pediatric, Adolescent and Young Adult Section, Joslin Diabetes Center; Department of Pediatrics, Harvard Medical School, Boston, MA.
⁴ Division of Endocrinology, Keck School of Medicine of the University of Southern California, Los Angeles, CA.

PMID: 24935775
PMCID: PMC5865481
DOI: 10.2337/dc14-1140

Type 1 diabetes through the life span: a position statement of the American Diabetes Association

Jane L Chiang et al. Diabetes Care. 2014 Jul.

. 2014 Jul;37(7):2034-54.

doi: 10.2337/dc14-1140.

Authors

Jane L Chiang¹, M Sue Kirkman², Lori M B Laffel³, Anne L Peters⁴; Type 1 Diabetes Sourcebook Authors

Collaborators

Type 1 Diabetes Sourcebook Authors:
Nora Algothani, Pamela Allweiss, Barbara J Anderson, Florence M Brown, H Peter Chase, William L Clarke, Sheri R Colberg, Kathleen Dungan, Steven Edelman, Martha M Funnell, Stephen E Gitelman, Ann E Goebel-Fabbri, Jeffrey S Gonzalez, Carla J Greenbaum, Michael J Haller, Kara Hawkins, Laurie A Higgins, Irl B Hirsch, William C Hsu, Heba Ismail, Crystal Crismond Jackson, Tamarra James-Todd, Georgeanna J Klingensmith, David C Klonoff, Mary Korytkowski, David Maahs, Hussain Mahmud, Medha N Munshi, Trevor Orchard, Bruce A Perkins, Jeremy Hodson Pettus, Andrew M Posselt, Michael C Riddell, Elizabeth R Seaquist, Janet Silverstein, Linda M Siminerio, Peter Stock, William V Tamborlane, Guillermo E Umpierrez, Raynard Washington, Joseph I Wolfsdorf, Howard Wolpert, Jennifer Ann Wyckoff, Mary Ziotas Zacharatos

Affiliations

¹ American Diabetes Association, Alexandria, VA jchiang@diabetes.org.
² Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.
³ Pediatric, Adolescent and Young Adult Section, Joslin Diabetes Center; Department of Pediatrics, Harvard Medical School, Boston, MA.
⁴ Division of Endocrinology, Keck School of Medicine of the University of Southern California, Los Angeles, CA.

PMID: 24935775
PMCID: PMC5865481
DOI: 10.2337/dc14-1140

No abstract available

PubMed Disclaimer

Figures

**Figure 1**
The percentage of antibody-positive subjects is affected by the duration of type 1 diabetes for GADA (A) and IA2A (B). Given an increase in the scatter (due to lower numbers of subjects), the x-axis is truncated at a duration of 30 years. Reproduced with permission from Tridgell et al. (16).

See this image and copyright information in PMC

Cited by

Perspectives of patients with type 1 and type 2 diabetes on barriers to diabetes care: a qualitative study.
Shrestha S, Sapkota S, Acharya K, Chaulagain S, Sayami M, Dahal A, Shakya R, Karmacharya BM. Shrestha S, et al. BMC Health Serv Res. 2024 Nov 18;24(1):1420. doi: 10.1186/s12913-024-11925-w. BMC Health Serv Res. 2024. PMID: 39551734 Free PMC article.
The Association of Sociodemographic Factors and Utilization of Diabetes Technologies with Diabetes Management: An Investigation in Children and Adolescents with Type 1 Diabetes.
Donbaloğlu Z, Barsal Çetiner E, Tuhan H, Parlak M. Donbaloğlu Z, et al. Turk Arch Pediatr. 2024 Sep 2;59(5):454-460. doi: 10.5152/TurkArchPediatr.2024.24093. Turk Arch Pediatr. 2024. PMID: 39440383 Free PMC article.
Age-based challenges to type 1 diabetes management in the pediatric population.
Lan YY, Kovinthapillai R, Kędzia A, Niechciał E. Lan YY, et al. Front Pediatr. 2024 Sep 2;12:1434276. doi: 10.3389/fped.2024.1434276. eCollection 2024. Front Pediatr. 2024. PMID: 39286453 Free PMC article. Review.
Metabolic health in people living with type 1 diabetes in Belgium: a repeated cross-sectional study.
Lavens A, De Block C, Oriot P, Crenier L, Philips JC, Vandenbroucke M, Vanherwegen AS, Nobels F, Mathieu C; IQED Group of Experts. Lavens A, et al. Diabetologia. 2024 Dec;67(12):2678-2690. doi: 10.1007/s00125-024-06273-7. Epub 2024 Sep 13. Diabetologia. 2024. PMID: 39271516
Heterogeneous response of estimated insulin sensitivity indices to metformin in young individuals with type 1 diabetes and different phenotypes.
Ramaldes LAL, Dos Santos SS, Dualib PM, de Sa JR, Dib SA. Ramaldes LAL, et al. Diabetol Metab Syndr. 2024 Sep 2;16(1):214. doi: 10.1186/s13098-024-01451-4. Diabetol Metab Syndr. 2024. PMID: 39218890 Free PMC article.

See all "Cited by" articles

References

1. Prime Group for JDRF Type 1 Diabetes, 2010 JDRF, 2011
1. Lawrence JM, Imperatore G, Pettitt DJ, et al. SEARCH for Diabetes in Youth Study Group. Incidence of diabetes in U.S. youth by type , race/ethnicity, and age, 2008–2009. Diabetes 2014;63(Suppl. 1):A407.
1. Harjutsalo V, Sjöberg L, Tuomilehto J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 2008;371:1777–1782 - PubMed
1. Pettitt DJ, Talton J, Dabelea D, et al. SEARCH for Diabetes in Youth Study Group Prevalence of diabetes in U.S. youth in 2009: the SEARCH for Diabetes in Youth study. Diabetes Care 2014;37:402–408 - PMC - PubMed
1. Hawa MI, Kolb H, Schloot N, et al. Action LADA consortium Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7. Diabetes Care 2013;36:908–913 - PMC - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

K12 HD051959/HD/NICHD NIH HHS/United States

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] Prime Group for JDRF Type 1 Diabetes, 2010 JDRF, 2011

[2] Prime Group for JDRF Type 1 Diabetes, 2010 JDRF, 2011

[3] Lawrence JM, Imperatore G, Pettitt DJ, et al. SEARCH for Diabetes in Youth Study Group. Incidence of diabetes in U.S. youth by type , race/ethnicity, and age, 2008–2009. Diabetes 2014;63(Suppl. 1):A407.

[4] Lawrence JM, Imperatore G, Pettitt DJ, et al. SEARCH for Diabetes in Youth Study Group. Incidence of diabetes in U.S. youth by type , race/ethnicity, and age, 2008–2009. Diabetes 2014;63(Suppl. 1):A407.

[5] Harjutsalo V, Sjöberg L, Tuomilehto J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 2008;371:1777–1782 - PubMed

[6] Harjutsalo V, Sjöberg L, Tuomilehto J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 2008;371:1777–1782 - PubMed

[7] Pettitt DJ, Talton J, Dabelea D, et al. SEARCH for Diabetes in Youth Study Group Prevalence of diabetes in U.S. youth in 2009: the SEARCH for Diabetes in Youth study. Diabetes Care 2014;37:402–408 - PMC - PubMed

[8] Pettitt DJ, Talton J, Dabelea D, et al. SEARCH for Diabetes in Youth Study Group Prevalence of diabetes in U.S. youth in 2009: the SEARCH for Diabetes in Youth study. Diabetes Care 2014;37:402–408 - PMC - PubMed

[9] Hawa MI, Kolb H, Schloot N, et al. Action LADA consortium Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7. Diabetes Care 2013;36:908–913 - PMC - PubMed

[10] Hawa MI, Kolb H, Schloot N, et al. Action LADA consortium Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7. Diabetes Care 2013;36:908–913 - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Type 1 diabetes through the life span: a position statement of the American Diabetes Association

Collaborators

Affiliations

Type 1 diabetes through the life span: a position statement of the American Diabetes Association

Authors

Collaborators

Affiliations

Figures

Similar articles

Cited by

References

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Figures

Similar articles

Cited by

References

MeSH terms

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical